COMPLETED

Otoacoustic Emission Suppression Study

Otoacoustic Emission Suppression in Clinical Populations

NCT04749524•Intelligent Hearing Systems

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Neonatal Hearing Loss

Interventions

Medial-Olivocochlear Reflex (MOCR) Strength Measurement

Locations

1

United States

Locations (1)

Vanderbilt University Medical School

Nashville, Tennessee, United States

Key Dates

Start Date

April 1, 2020

Primary Completion Date

June 23, 2023

Completion Date

July 12, 2023

Last Updated

August 16, 2024

Sponsors

Lead Sponsor

Intelligent Hearing Systems

Collaborators

National Institute on Deafness and Other Communication Disorders (NIDCD)
Vanderbilt University

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 16, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions